PRESS RELEASE published on 07/13/2026 at 21:17, 2 months 20 days ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook Evotec SE announces preliminary second quarter and first half 2026 results and updates full-year 2026 outlook, reflecting adjusted financial figures and revised guidance Evotec SE Preliminary Results Financial Figures Full-year Outlook Revised Guidance
BRIEF published on 06/30/2026 at 07:35, 3 months 3 days ago Evotec AG présente J.TRAIN, une solution de fabrication de produits biologiques efficace. Productivité Produits Biologiques Efficacité En Matière De Coûts Fabrication Continue J.TRAIN
BRIEF published on 06/30/2026 at 07:35, 3 months 3 days ago Evotec AG Introduces J.TRAIN for Efficient Biologics Manufacturing Productivity Cost Efficiency Biologics Continuous Manufacturing J.TRAIN
PRESS RELEASE published on 06/30/2026 at 07:30, 3 months 3 days ago Just – Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics Evotec SE introduces J.TRAIN, a turnkey continuous manufacturing solution for biologics, enabling faster deployment and increased productivity. The model combines modular infrastructure, equipment, and technology for efficient capacity increase Technology Evotec SE Biologics Continuous Manufacturing J.TRAIN
BRIEF published on 06/11/2026 at 15:35, 3 months 21 days ago Evotec annonce les résultats de son assemblée générale annuelle de 2026 Evotec SE Conseil De Surveillance Assemblée Générale Annuelle Vote Des Actionnaires Découverte De Médicaments
BRIEF published on 06/11/2026 at 15:35, 3 months 21 days ago Evotec Announces Outcomes of 2026 Annual General Meeting Annual General Meeting Drug Discovery Evotec SE Supervisory Board Shareholder Voting
PRESS RELEASE published on 06/11/2026 at 15:30, 3 months 21 days ago Evotec Reports Results of the Annual General Meeting 2026 Evotec SE reports the results of its 2026 Annual General Meeting, including newly elected Supervisory Board members and voting outcomes. For more details, visit their website Annual General Meeting Shareholders Voting Results Evotec SE Supervisory Board
BRIEF published on 06/02/2026 at 07:35, 4 months 1 day ago Evotec Appoints Rui Wang as Head of Global In Silico and AI Drug Discovery Evotec SE AI In Pharma Rui Wang In Silico Innovation
BRIEF published on 06/02/2026 at 07:35, 4 months 1 day ago Evotec nomme Rui Wang à la tête de ses activités mondiales de modélisation in silico et d'IA. Evotec SE Découverte De Médicaments L'IA Dans L'industrie Pharmaceutique Rui Wang Innovation In Silico
PRESS RELEASE published on 06/02/2026 at 07:30, 4 months 1 day ago Evotec Appoints Rui Wang as Head of Global In Silico and AI Evotec SE appoints Rui Wang as Head of Global In Silico and AI, bringing over 20 years of experience in enterprise data and AI strategies for pharmaceutical and biotechnology operations Biotechnology AI Pharmaceutical Evotec Rui Wang
Published on 10/03/2026 at 02:35, 9 hours 1 minute ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 21 hours 46 minutes ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 22 hours 36 minutes ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 22 hours 36 minutes ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/02/2026 at 23:55, 11 hours 41 minutes ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 15 hours 12 minutes ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 15 hours 50 minutes ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 16 hours 36 minutes ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 18:00, 17 hours 36 minutes ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 17 hours 51 minutes ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 17 hours 51 minutes ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 18 hours 1 minute ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 18 hours 6 minutes ago Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 18 hours 6 minutes ago Aéroports de Paris SA - Calendrier financier 2027